Bright Minds Biosciences Operating Cash Flow Growth & History (DRUG)
Bright Minds Biosciences's operating cash flow was −$8.7M for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual operating cash flow history
| Fiscal year | Period ended | Operating cash flow | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −$8.7M | −$6.8M | — |
| 2024 | 2024-09-30 | −$1.9M | $5.2M | — |
| 2023 | 2023-09-30 | −$7.0M | $6.6M | — |
| 2022 | 2022-09-30 | −$13.6M | −$6.3M | — |
| 2021 | 2021-09-30 | −$7.3M | −$7.0M | — |
| 2020 | 2020-09-30 | −$288,392 | — | — |
Bright Minds Biosciences quarterly operating cash flow
| Fiscal quarter | Period ended | Operating cash flow | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | −$8.3M | −$4.8M | — |
| Q2 2026 | 2026-03-31 | −$9.2M | −$6.8M | — |
| Q1 2026 | 2025-12-31 | −$5.8M | — | — |
| Q4 2025 | 2025-09-30 | −$1.3M | — | — |
| Q3 2025 | 2025-06-30 | −$3.5M | — | — |
| Q2 2025 | 2025-03-31 | −$2.4M | — | — |
Bright Minds Biosciences operating cash flow trends
Over the last five fiscal years, Bright Minds Biosciences's operating cash flow decreased from −$288,392 to −$8.7M, a change of −$8.4M. The latest reported quarter, Q3 2026, shows −$8.3M.
What operating cash flow means
Operating cash flow is the cash generated or used by a company’s core operations. It incorporates working-capital movements and other operating cash items, and it is the starting point for calculating free cash flow.
SEC-reported operating cash flow
TickerStat standardizes net cash provided by or used in operating activities reported in company SEC filings. It is historical filing data before capital expenditures, financing activities, and investing activities. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗